These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 38373185

  • 21. A Retrospective Study of Cytology, High-Risk HPV, and Colposcopy Results of Vaginal Intraepithelial Neoplasia Patients.
    Cong Q, Song Y, Wang Q, Zhang H, Gao S, Sui L.
    Biomed Res Int; 2018; 2018():5894801. PubMed ID: 29854768
    [Abstract] [Full Text] [Related]

  • 22. High-grade vaginal intraepithelial neoplasia after hysterectomy for high-grade cervical intraepithelial neoplasia: Is hysterectomy a "definitive" treatment compared to conization?
    Tanaka M, Yamanoi K, Taki M, Kitamura S, Sunada M, Chigusa Y, Horie A, Yamaguchi K, Hamanishi J, Mandai M.
    J Obstet Gynaecol Res; 2023 Sep; 49(9):2361-2369. PubMed ID: 37354106
    [Abstract] [Full Text] [Related]

  • 23. Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: a comprehensive analysis of 576 cases.
    Kim MK, Lee IH, Lee KH.
    J Gynecol Oncol; 2018 Jan; 29(1):e6. PubMed ID: 29185264
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.
    Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J.
    Lancet; 2007 May 19; 369(9574):1693-702. PubMed ID: 17512854
    [Abstract] [Full Text] [Related]

  • 25. Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus.
    Sherman JF, Mount SL, Evans MF, Skelly J, Simmons-Arnold L, Eltabbakh GH.
    Gynecol Oncol; 2008 Sep 19; 110(3):396-401. PubMed ID: 18586314
    [Abstract] [Full Text] [Related]

  • 26. Human papillomavirus in vaginal intraepithelial neoplasia.
    Chao A, Chen TC, Hsueh C, Huang CC, Yang JE, Hsueh S, Huang HJ, Lin CT, Tang YH, Liou JD, Chang CJ, Chou HH, Lai CH.
    Int J Cancer; 2012 Aug 01; 131(3):E259-68. PubMed ID: 22095387
    [Abstract] [Full Text] [Related]

  • 27. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).
    Srodon M, Stoler MH, Baber GB, Kurman RJ.
    Am J Surg Pathol; 2006 Dec 01; 30(12):1513-8. PubMed ID: 17122506
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of Poly-Gamma-Glutamic Acid in Women with High-Risk Human Papillomavirus-Positive Vaginal Intraepithelial Neoplasia: an Observational Pilot Study.
    Koo YJ, Min KJ, Hong JH, Lee JK.
    J Microbiol Biotechnol; 2015 Jul 01; 25(7):1163-9. PubMed ID: 25907060
    [Abstract] [Full Text] [Related]

  • 29. Vulvar and Vaginal Cancer, Vulvar Intraepithelial Neoplasia 3 and Vaginal Intraepithelial Neoplasia 3: Experience of a Referral Institute.
    Siegler E, Segev Y, Mackuli L, Auslender R, Shiner M, Lavie O.
    Isr Med Assoc J; 2016 May 01; 18(5):286-9. PubMed ID: 27430086
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y, Ang Q, Wu H, Xu J, Chen D, Zhao H, Liu H, Guo X, Gu Y, Qiu H.
    Virol J; 2020 Jul 13; 17(1):104. PubMed ID: 32660490
    [Abstract] [Full Text] [Related]

  • 31. Detection of high-risk human papillomavirus infection and treatment of high-grade vaginal intraepithelial neoplasia: A single-institution study.
    Cho HW, Hong JH, Lee JK.
    Int J Gynaecol Obstet; 2021 Aug 13; 154(2):227-232. PubMed ID: 33411347
    [Abstract] [Full Text] [Related]

  • 32. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
    Lin CT, Qiu JT, Wang CJ, Chang SD, Tang YH, Wu PJ, Jung SM, Huang CC, Chou HH, Jao MS, Lai CH.
    Taiwan J Obstet Gynecol; 2012 Dec 13; 51(4):533-8. PubMed ID: 23276555
    [Abstract] [Full Text] [Related]

  • 33. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    BMC Cancer; 2022 Jan 06; 22(1):42. PubMed ID: 34991494
    [Abstract] [Full Text] [Related]

  • 34. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort.
    Chen Y, Qiu X, Wang W, Li D, Wu A, Hong Z, Di W, Qiu L.
    BMC Infect Dis; 2020 Aug 26; 20(1):629. PubMed ID: 32842982
    [Abstract] [Full Text] [Related]

  • 35. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer.
    Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM.
    J Med Virol; 2004 Sep 26; 74(1):117-26. PubMed ID: 15258977
    [Abstract] [Full Text] [Related]

  • 36. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer.
    Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V.
    Obstet Gynecol; 2006 Dec 26; 108(6):1361-8. PubMed ID: 17138767
    [Abstract] [Full Text] [Related]

  • 37. Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial.
    Garland SM, Paavonen J, Jaisamrarn U, Naud P, Salmerón J, Chow SN, Apter D, Castellsagué X, Teixeira JC, Skinner SR, Hedrick J, Limson G, Schwarz TF, Poppe WA, Bosch FX, de Carvalho NS, Germar MJ, Peters K, Del Rosario-Raymundo MR, Catteau G, Descamps D, Struyf F, Lehtinen M, Dubin G, HPV PATRICIA Study Group.
    Int J Cancer; 2016 Dec 15; 139(12):2812-2826. PubMed ID: 27541373
    [Abstract] [Full Text] [Related]

  • 38. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK.
    J Gynecol Oncol; 2018 Jan 15; 29(1):e14. PubMed ID: 29185272
    [Abstract] [Full Text] [Related]

  • 39. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.
    Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.
    Obstet Gynecol; 2018 Aug 15; 132(2):261-270. PubMed ID: 29995724
    [Abstract] [Full Text] [Related]

  • 40. Comparison of methods using paraffin-embedded tissues and exfoliated cervical cells to evaluate human papillomavirus genotype attribution.
    Torii Y, Fujii T, Kukimoto I, Saito M, Iwata T, Takahashi H, Ichikawa R, Kawai S, Otani S, Aoki D.
    Cancer Sci; 2016 Oct 15; 107(10):1520-1526. PubMed ID: 27501394
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.